NEW YORK — Aetna this week updated its coverage policy to include noninvasive prenatal testing (NIPT) for all pregnancies.
According to Aetna's updated policy, the Hartford, Connecticut-based insurer now considers NIPT using measurement of cell-free fetal nucleic acids in maternal blood to be medically necessary for screening for fetal aneuploidy in all pregnant women.